Tizanidine Tablet
Product Images NDC 63629-2371

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-2371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
The text describes the improvement in Ashworth Score with dosage mentioned in mg over a certain period of time in a study. It mentions the end of titration and maintenance with the last observation carried forward as the endpoint.*
FDA Label Image

Label (Lbl636292371)

Label (Lbl636292371)
This text describes medication called "Tizanidine Tablets, USP" containing 4.567 mg tizanidine HCI, equivalent to 4 mg of tizanidine base. It instructs to keep the medication out of reach of children, store it at room temperature, and dispense it in a child-resistant container. The NDC number for this medication is 63629-2371-1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.